Buy or sell Foundation Medicine stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Foundation Medicine Stock

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

About Foundation Medicine Stock

Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.

Funding History

April 2010$7.0M
October 2011$33.5M
September 2012$42.5M
January 2013$13.5M


Vice President of Knowledge Informatics

Eric Neumann

Medical Director, Interim Head of Pathology & Molecular Diagnostics

Jeffrey Ross

President & CEO

Michael J. Pellini

Chief Business Officer

Steven J. Kafka

Co - Founder & Chairman of the Board

Alexis Borisy


Ronald Collette

VP, Finance

Jason Ryan

VP, Human Resources

Sarah Larson

Leader, Cancer Immunotherapy

David Fabrizio

Chief Commercial Officer & SVP, International Strategy

Kevin Krenitsky


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Foundation Medicine or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: